Sildenafil Tablet
Product Images NDC 50268-717

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50268-717). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 5026871715 Sildenafil 2015 20mg

This is a product description of Sildenafil tablets. The packaging is available in 5 10 unit doses. The rest of the text is not readable.*

FDA Label Image

F7c6df1a-figure-01 (Sildenafil Tablets 1)

This appears to be a table displaying three different dosage levels - high, medium, and low - for an undefined medication. It is possible that this information is part of a larger document or study detailing the efficacy of these various dosages.*

FDA Label Image

F7c6df1a-figure-02 (Sildenafil Tablets 2)

FDA Label Image

F7c6df1a-figure-03 (Sildenafil Tablets 3)

This text mentions different drugs and their recommended dose adjustments when taken with Sildenafil. Atorvastatin, Oral Contraceptives, and Ritonavir do not require any dose adjustment. Bosentan, Cimetidine, and Erythromycin require no dose adjustment for AUC but caution is recommended for Cmax. Dosage adjustment is recommended for Azithromycin with AUC and Cmax. However, specific details on the dosage adjustment are not present. The last sentence mentions that taking sildenafil with bosentan does not have any benefit on exercise capacity.*

FDA Label Image

F7c6df1a-figure-04 (Sildenafil Tablets 4)

This is a list of drugs and their interactions with Acenocoumarol. The table lists the AUC and Cmax values for each drug when administered concomitantly with Acenocoumarol. Additionally, the fold change and 90% CI values are listed. Based on the data, it recommends no dose adjustment for most drugs except Doxazosint and bosentan, and Ritonavir and Sildenafil which are not recommended for concomitant use.*

FDA Label Image

F7c6df1a-figure-05 (Sildenafil Tablets 5)

FDA Label Image

F7c6df1a-figure-06 (Sildenafil Tablets 6)

This is a medical prescription and associated data related to medication called Sidorati. The dosage prescribed is 20mg to be taken three times a day. The rest of the text appears to be related to assessment and evaluation of treatment for a particular medical condition (possibly pulmonary arterial hypertension) and includes details such as functional capacity, therapeutic class, and median 6-minute walk distance.*

FDA Label Image

F7c6df1a-figure-07 (Sildenafil Tablets 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.